Management

Bertrand Jungo
Vice-Chairman of the Board of Directors

• Board member since 2018, born in 1965, Swiss citizen
• Corporate Governance: independent member
• Career highlights: From 2006 to 2017, he held the position of CEO of the Swiss department store group Manor. From 2017 until February 2020, he was CEO of Admeira AG, and from 2020 to July 2021, he served as a member of the Board of Directors at Admeira AG. He was also a member of the Advisory Board of the International Retail Summit (IRS) of the Gottlieb Duttweiler Institute (GDI) (2010 – July 2021).
• Qualification: Degree as business administrator lic.rer.pol from the University of Fribourg.
• Other main activities: Since August 2021, he has been a delegate of the Board of Directors of the Kulm-Group St. Moritz. Furthermore, he is a member of the Board of Neoperl AG as well as at Zoo Basel.

Pascale Bruderer

• Board member since 2020, born in 1977, Swiss citizen
• Corporate Governance: independent member
• Career highlights: Pascale Bruderer was a member of the National council from 2002 to 2011 (president of the National council 2009/2010) and a Member of the Council of States from 2011 to 2019. She was formerly a member of the Social Security and Health Committee. She served as president of the umbrella organisation for disabled people, Inclusion Handicap, and was the managing director of Krebsliga Aargau.
• Qualification: Master’s degree in political science from the University of Zurich and education at Harvard University in Boston (USA) and at the Executive School of the University of St. Gallen.
• Other main activities: Pascale Bruderer is a member of the Board of Directors of the Bernexpo Group, Tamedia and the TX Group AG. Furthermore, since 2019, she has been a co-owner and member of the executive Board of Crossiety AG.

Prof. Hon. Dr. Michel Burnier

• Board member since 2017, born in 1953, Swiss citizen
• Corporate Governance: independent member
• Career highlights: Prof. Hon. Dr Michel Burnier was a member of the Medicines Committee of the Swiss Association of Pharmacists until 2001 and served on the boards of Swissmedic from 2002 to 2010 and Speedel Holding AG from 2007 to 2009.
• Qualification: Swiss-registered Doctor of Internal Medicine and Nephrology.
• Other main activities: Prof. Hon. Dr Michel Burnier is currently Professor Emeritus at the University of Lausanne, where he was the head of the Service of Nephrology and Hypertension until July 2019 and Professor at the Medical University of Gdansk (Poland). Furthermore, he is currently on the Board of Vifor Pharma AG and is a member of the Swiss Society of Nephrology (former President), the Scientific Council of the European Society of Hypertension (former Treasurer) and the Swiss Society of Hypertension (former President). Since 2020, he has been a member of the Board of Fondation Mérine and the Editor in Chief of the journal Blood Pressure since 2022.

Dr. Markus R. Neuhaus

• Board member since 2019, born in 1958, Swiss citizen
• Corporate Governance: independent member
• Career highlights: Dr Markus R. Neuhaus held various roles at PwC from 1985 on, including CEO of PwC Switzerland from 2003 to 2012, member of PwC’s Global Board from 2005 to 2007, member of the PwC Network Executive Team from 2010 to 2013, member of PwC’s Office of the Global Chairman from 2013 to 2016, and Chairman of PwC Switzerland from 2012 to 2019.
• Qualification: Master of law and doctorate in law from the University of Zurich. Certified tax expert. Various management courses at international business schools (Harvard, Insead, IMD).
• Other main activities: Dr Markus R. Neuhaus is Vice-Chairman of the Board of Directors of Barry Callebaut AG and Orior AG and a member of the Board of Directors of Baloise AG and Jacobs Holding AG. He also serves as Vice-Chair of the Board of Trustees of Avenir Suisse.

Dr. Andreas Walde

• Board member since 2017, born in 1962, Swiss citizen
• Corporate Governance: independent member
• Career highlights: After completing his studies and being admitted to the Swiss Bar, he held various legal and management positions in international chemical and pharmaceutical companies for more than 30 years with a focus on corporate governance, remuneration systems, sustainability, risk management, ethics and compliance, as well as on financial and corporate structures and M&A, e.g. at Roche (1988–1996), Clariant (1998–2010), Petroplus (2012–2013) and Vifor Pharma (since 2013). His former positions include memberships on the board of several private and (non-Swiss) public listed companies. He is a member of the board of scienceindustries and has served on the boards of SwissHoldings and the Society of Swiss Enterprises in Germany.
• Qualification: Attorney-at-law and doctorate in law from the University of Basel.
• Other main activities: Dr Andreas Walde is General Secretary of Vifor Pharma AG.

Lukas Ackermann
Chief IT & Digital Services Officer

• Member of the Executive Committee of the Galenica Group since 2022, born in 1972, Swiss citizen
• Career highlights: Lukas Ackermann started off his career as Product Manager at Helsana Insurance Company Ltd and then became Deputy Head of Product Management (1999 – 2002). In 2002, he was appointed CEO of Medicall Ltd. Afterwards, he became Head of Health Care Market at Synesix Ltd (2008 – 2010). The two following years, Lukas Ackermann was Head of I-Lab at the University of St.Gallen, and from 2013 to 2020 he was General Manager / CEO of amétiq Ltd. Before Lukas Ackermann became Head of IT & Digital Services at Galenica Ltd at the Galenica Group in 2021, he was Managing Director of HCI Solutions Ltd.
• Qualification: He obtained a Diploma in Natural Sciences from Federal Institute of Technology (ETH) Zurich and has a MAS MTEC from the Federal Institute of Technology (ETH) Zurich.

Felix Burkhard
CFO Galenica Group

• Member of the Executive Committee of the Galenica Group since 2010, born in 1966, Swiss citizen
• Career highlights: From 1991 to 1994, Felix Burkhard acted as Financial Auditor at Revisuisse PriceWaterhouse in Berne and 1995 as Head of Finance and Controlling at Amidro AG in Biel-Bienne. He joined the former Galenica Group in 1996 as Corporate Controller before becoming Deputy Head Retail Business sector in 2000. In 2008, he was named Head of the Amavita pharmacy chain and later Head Retail Business sector (2010 – 2015). Felix Burkhard then moved into the role of Head Strategic Projects (2015 – 2017). He has served as a member of the Corporate Executive Committee of the Galenica Group since 2010.
• Qualification: Lic. oec. at the University of St. Gallen (HSG), and Swiss certified accountant.

Andreas Koch
Head of Wholesale & Logistics

• Member of the Executive Committee of the Galenica Group since 2020, born 1971, German and Swiss citizen
• Career highlights: Between 2000 and 2009, Andreas Koch worked in different consulting and management functions in the field of supply chain management at various consulting firms. He then became Head of Supply Chain Management at Galexis – from 2011 also at Alloga – and was a member of both Executive Committees. In 2015, he rose to the position of Head of Alloga, after which he became Head of Galexis in 2019. In 2020, Andreas Koch took over the responsibility for the Services Business Sector at Galenica.
• Qualification: He completed an apprenticeship as forwarding & logistics manager before studying business administration at the University of Mannheim, and graduated with a degree in business administration. He later completed the Programme for Executive Development (PED) at IMD Lausanne.

Virginie Pache
Chief Pharmacies Officer

• Member of the Executive Committee of the Galenica Group since 2020, born in 1979, Swiss citizen
• Career highlights: After completing her studies, Virginie Pache started working as a Junior Marketing Manager at Danone Schweiz AG (mineral water) in Fribourg (2003 – 2006). Afterwards, she became Category Manager and Head of Sales at L’Oréal – Apothekenkosmetik Schweiz AG (2006-2010). She then was appointed Head of Caudalie Suisse (and Poland ad interim) and afterwards Caudalie D-A-CH GmbH in Switzerland, then in Düsseldorf, Germany (2010–2018), before she became Head of Coop Vitality in 2018.
• Qualification: Masters in Political Sciences – University of Lausanne and three semesters in Mainz (Germany)

Dr. Thomas Szuran
Chief Products & Marketing Officer

• Born 1967, Swiss citizen
• Dr. sc. nat. Federal Institute of Technology (ETH) Zurich
• Various roles at Abbott Laboratories between 1997 and 2002, including Sales & Marketing Manager for the Eastern European & Mediterranean region
• Sales Director at Pfizer Switzerland (Zurich) from 2002 to 2005 and Country Manager at Pfizer in Israel from 2005 to 2007
• Joined Biomed Ltd. (Dübendorf) in 2008 as Marketing Director, and was CEO of Biomed Ltd. from 2011 to 2018
• Since 2012 member of the Executive Board and since 2013 President of the Association of the Swiss Self-Medication Industry (ASSGP)
• Head Products & Brands Business sector and member of the Corporate Executive Committee of the Galenica Group since 2019

Christina Hertig
Head of Corporate Communications

• Member of the Extended Executive Committee of the Galenica Group since 2017, born in 1966, Swiss citizen
• Career highlights: From 1985 to 1986 Christina Hertig was in charge of various projects at the advertising agency Lesch + Frei. After having completed her studies, she joined the editorial team of the members newspaper of the Schweizerische Metallunion (1991 - 1994). In 1995, she became Head of Sponsoring at Publisuisse Ltd, a year later she was appointed Head of Corporate Communications at Prodega Ltd (later Bon appétit Group). In 2002, she moved to the Federal Office of Public Health (FOPH)as Head of Communication. Since 2006, Christina Hertig is Head of Corporate Communications at the Galenica Group. In 2017, she became a member of the extended Corporate Executive Committee, and in 2021, member of the extended Executive Committee.
• Qualification: She obtained a Federal Diploma in PR Consultancy and a Federal Diploma in Translation at the Interpreters’ School in Zurich. Furthermore, she studied HR Strategy in Transforming Organisations at the London Business School.
• Other main activity: Since 2019, she is a member of the GEWA Advisory council in Berne.

Jürg Pauli
Chief Transformation Officer

• Member of the Extended Executive Committee of the Galenica Group since 2021, born in 1964, swiss citizen
• Career highlights: Jürg Pauli started off his career as a lawyer at the Swiss Bank Corporation (1993 – 1995) and as lawyer and member of the Executive Committee at a law firm (1995 – 1999). From 1999 to 2005 he worked in various roles at Swisscom Mobile, before he became first Head of Marketing Communications and then Head of Marketing at Swisscom Mobile in 2005. Three years later, he joined the Swisscom Group as Head of Pricing and Portfolio Design. Afterwards, Jürg Pauli was appointed Head of Marketing Swisscom and member of the Executive Board for Swisscom (Switzerland) Ltd (2013 – 2016). In 2016, he became Head of Business Transformation at Swisscom. Since 2020, he is Head of Transformation and Organisational Development at Galenica Ltd and member of the extended Executive Committee.
• Qualification: He has studied law at the University of Berne and qualified as an advocate/attorney at law before he did his Executive MBA at Bern-Rochester. He later made a training Transformation for Executives at IMD Lausanne plus the CAS in Agile Leadership.

Barbara Wälchli
General Counsel & Secretary of the Board of Directors

• Member of the Extended Executive Committee of the Galenica Group since 2021, born in 1981, Swiss citizen
• Career highlights: From 2011 to 2018, Barbara Wälchli worked as attorney at law in various corporate law firms in Berne and Zurich. In 2018, she joined the Galenica Group as Senior Legal Counsel. In the following year, she became General Counsel of the Galenica Group. Since 2020, Barbara Wälchli acts as General Secretary and since 2021 as a member of the extended Executive Committee.
• Qualification: MLAW, LLM, attorney at law